Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2055506Generated: November 2, 2026

(1-methyl-1H-imidazol-5-yl)methanol → 1'-({6-Chloro-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-indol-3-yl}carbonyl)-5-fluoro-3H-spiro[2-benzofuran-1,4'-piperidin]-3-one

https://huagongshe.com/reaction/2055506

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(1-methyl-1H-imidazol-5-yl)methanolHCID 2773450—
Reactant1'-[(6-chloro-1H-indol-3-yl)carbonyl]-5-fluoro-3H-spiro[2-benzofuran-1,4'-piperidin]-3-oneHCID 59657623—
Reactantmethanesulfonic acid 3-methyl-3H-imidazol-4-ylmethyl esterHCID 86610241—
Product1'-({6-Chloro-1-[(1-methyl-1H-imidazol-5-yl)methyl]-1H-indol-3-yl}carbonyl)-5-fluoro-3H-spiro[2-benzofuran-1,4'-piperidin]-3-oneHCID 59657520—

Reaction Steps

Following the general procedure III as described above, the alkylation of 1′-[(6-chloro-1H-indol-3-yl)carbonyl]-5-fluoro-3H-spiro[2-benzofuran-1,4′-piperidin]-3-one (prepared according to example 19) with methanesulfonic acid 3-methyl-3H-imidazol-4-ylmethyl ester (prepared by mesylation of the commercially available (3-methyl-3H-imidazol-4-yl)-methanol) gave the title compound. ES-MS m/e (%): 493.1(M+H+).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07332501B2
Source datasetuspto-grants-2008_02
ORD IDord-bb32c2e5a1fb4396b48074597dbb2685
Source noteuspto-grants-2008_02